Hong Kong is fast becoming one of Asia’s most strategic gateways for life science and MedTech innovation — not just as a market, but as a platform for clinical validation, fundraising, IP protection, and regional scaling.
On 11 February 2026, the Hong Kong Chamber of Commerce in Sweden together with the Hong Kong Trade Development Council, is bringing these insights directly to the Malmö–Lund area in Southern Sweden:
Hong Kong as a Gateway to Asia: Scaling Swedish MedTech Innovation
📍 Embassy House, Lund
🕗 08:00–10:00 CET
Register here: https://forms.cloud.microsoft/pages/responsepage.aspx?id=lQ8Y3ujupEKcq9wt1s4-0EPQvK5czDlFhX6Bh9-VKydUOEpBVUlYRlpaTDZPSk9CWEhPTEM0VElXMy4u&route=shorturl
We are pleased to have Foodworks – Foodtech Hub & Labs and LucyJRobertshaw supporting this event as local supporting partners — strengthening the bridge between Nordic innovation and Hong Kong’s life-science platform.
This breakfast seminar will explore how Swedish MedTech and Biotech companies can leverage Hong Kong’s rapidly evolving life-science ecosystem — from the HeTao cross-border innovation corridor and clinical trial infrastructure to international fundraising and market entry into the Greater Bay Area and beyond.
The session builds on the Swedish Life Science Delegation to Hong Kong in December and marks the next step: translating dialogue into concrete collaboration opportunities.
Speakers Include:
• Hong Kong Trade Development Council
• Hong Kong–Shenzhen Innovation & Technology Park
• EQT Partners
• Hong Kong Chamber of Commerce in Sweden
If you are working in MedTech, Biotech, life science investment, or innovation policy — this is a practical opportunity to understand how Hong Kong can accelerate your Asia strategy.
Register by using the below link: https://forms.cloud.microsoft/pages/responsepage.aspx?id=lQ8Y3ujupEKcq9wt1s4-0EPQvK5czDlFhX6Bh9-VKydUOEpBVUlYRlpaTDZPSk9CWEhPTEM0VElXMy4u&route=shorturl
